Kidney Cancer Research Bureau Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Moscow Russian Federation (1951)

Organization Overview

First Clinical Trial
2004
NCT01176552
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Kidney Cancer Research Bureau